• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓源性抑制细胞的存活与功能受转录因子Nrf2调控。

Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.

作者信息

Beury Daniel W, Carter Kayla A, Nelson Cassandra, Sinha Pratima, Hanson Erica, Nyandjo Maeva, Fitzgerald Phillip J, Majeed Amry, Wali Neha, Ostrand-Rosenberg Suzanne

机构信息

Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250.

Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250

出版信息

J Immunol. 2016 Apr 15;196(8):3470-8. doi: 10.4049/jimmunol.1501785. Epub 2016 Mar 2.

DOI:10.4049/jimmunol.1501785
PMID:26936880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4821672/
Abstract

Tumor-induced myeloid-derived suppressor cells (MDSC) contribute to immune suppression in tumor-bearing individuals and are a major obstacle to effective immunotherapy. Reactive oxygen species (ROS) are one of the mechanisms used by MDSC to suppress T cell activation. Although ROS are toxic to most cells, MDSC survive despite their elevated content and release of ROS. NF erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates a battery of genes that attenuate oxidative stress. Therefore, we hypothesized that MDSC resistance to ROS may be regulated by Nrf2. To test this hypothesis, we used Nrf2(+/+)and Nrf2(-/-)BALB/c and C57BL/6 mice bearing 4T1 mammary carcinoma and MC38 colon carcinoma, respectively. Nrf2 enhanced MDSC suppressive activity by increasing MDSC production of H2O2, and it increased the quantity of tumor-infiltrating MDSC by reducing their oxidative stress and rate of apoptosis. Nrf2 did not affect circulating levels of MDSC in tumor-bearing mice because the decreased apoptotic rate of tumor-infiltrating MDSC was balanced by a decreased rate of differentiation from bone marrow progenitor cells. These results demonstrate that Nrf2 regulates the generation, survival, and suppressive potency of MDSC, and that a feedback homeostatic mechanism maintains a steady-state level of circulating MDSC in tumor-bearing individuals.

摘要

肿瘤诱导的髓源性抑制细胞(MDSC)在荷瘤个体中导致免疫抑制,并且是有效免疫治疗的主要障碍。活性氧(ROS)是MDSC用于抑制T细胞活化的机制之一。尽管ROS对大多数细胞有毒,但MDSC尽管其ROS含量和释放增加仍能存活。核因子E2相关因子2(Nrf2)是一种转录因子,可调节一系列减轻氧化应激的基因。因此,我们假设MDSC对ROS的抗性可能受Nrf2调节。为了验证这一假设,我们分别使用了携带4T1乳腺癌和MC38结肠癌的Nrf2(+/+)和Nrf2(-/-) BALB/c及C57BL/6小鼠。Nrf2通过增加MDSC产生H2O2来增强MDSC的抑制活性,并且通过降低其氧化应激和凋亡率来增加肿瘤浸润性MDSC的数量。Nrf2不影响荷瘤小鼠中MDSC的循环水平,因为肿瘤浸润性MDSC凋亡率的降低被骨髓祖细胞分化率的降低所平衡。这些结果表明,Nrf2调节MDSC的产生、存活和抑制能力,并且一种反馈稳态机制维持荷瘤个体中循环MDSC的稳态水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/1dfbb5c62ede/nihms759790f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/947c9d15fb3c/nihms759790f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/0ac714ba1bd1/nihms759790f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/1b0ea95eb5a3/nihms759790f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/99a2c4d61c2e/nihms759790f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/1dfbb5c62ede/nihms759790f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/947c9d15fb3c/nihms759790f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/0ac714ba1bd1/nihms759790f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/1b0ea95eb5a3/nihms759790f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/99a2c4d61c2e/nihms759790f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe4/4821672/1dfbb5c62ede/nihms759790f5.jpg

相似文献

1
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.髓源性抑制细胞的存活与功能受转录因子Nrf2调控。
J Immunol. 2016 Apr 15;196(8):3470-8. doi: 10.4049/jimmunol.1501785. Epub 2016 Mar 2.
2
Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment.适者生存:髓源性抑制细胞如何在恶劣的肿瘤微环境中存活。
Cancer Immunol Immunother. 2020 Feb;69(2):215-221. doi: 10.1007/s00262-019-02388-8. Epub 2019 Sep 9.
3
Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis.髓系谱系特异性抗氧化系统缺失增强肿瘤转移。
Cancer Prev Res (Phila). 2014 Aug;7(8):835-44. doi: 10.1158/1940-6207.CAPR-14-0094. Epub 2014 May 27.
4
Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.通过联合脂多糖和γ干扰素处理激活髓源性抑制细胞会损害树突状细胞的发育。
Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486.
5
Antigen specificity of immune suppression by myeloid-derived suppressor cells.髓系来源抑制细胞的免疫抑制的抗原特异性。
J Leukoc Biol. 2011 Jul;90(1):31-6. doi: 10.1189/jlb.0111021. Epub 2011 Apr 12.
6
Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.跨膜 TNF-α 通过 TNFR2 促进髓源性抑制细胞的抑制活性。
J Immunol. 2014 Feb 1;192(3):1320-31. doi: 10.4049/jimmunol.1203195. Epub 2013 Dec 30.
7
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.体外生成模拟结直肠癌肿瘤免疫抑制环境的髓源性抑制细胞。
Oncotarget. 2015 May 20;6(14):12369-82. doi: 10.18632/oncotarget.3682.
8
Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.酵母衍生的颗粒状β-葡聚糖治疗通过诱导癌症中多形核髓源性抑制细胞(MDSC)凋亡和单核细胞MDSC向抗原呈递细胞(APC)分化来颠覆MDSC的抑制作用。
J Immunol. 2016 Mar 1;196(5):2167-80. doi: 10.4049/jimmunol.1501853. Epub 2016 Jan 25.
9
Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.人头颈鳞状细胞癌相关的信号素4D诱导髓源性抑制细胞扩增。
J Immunol. 2016 Feb 1;196(3):1419-29. doi: 10.4049/jimmunol.1501293. Epub 2016 Jan 6.
10
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies.抑制脂肪酸氧化可调节髓源性抑制细胞的免疫抑制功能,并增强癌症治疗效果。
Cancer Immunol Res. 2015 Nov;3(11):1236-47. doi: 10.1158/2326-6066.CIR-15-0036. Epub 2015 May 29.

引用本文的文献

1
NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting.癌症中的NRF2免疫生物学:对免疫治疗和治疗靶点的影响。
Oncogene. 2025 Sep 13. doi: 10.1038/s41388-025-03560-4.
2
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours.髓系祖细胞失调助长肿瘤中的免疫抑制性巨噬细胞。
Nature. 2025 Sep 10. doi: 10.1038/s41586-025-09493-y.
3
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers.癌症中的氧化应激:从肿瘤与微环境重塑到治疗前沿

本文引用的文献

1
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.髓源性抑制细胞:肿瘤微环境中驱动免疫抑制的关键细胞
Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12.
2
Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.核因子(红细胞系衍生 2)相关因子 2(Nrf2)在胃癌中的表达的临床病理意义
BMC Cancer. 2015 Jan 15;15:5. doi: 10.1186/s12885-015-1008-4.
3
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.
Mol Cancer. 2025 Aug 22;24(1):219. doi: 10.1186/s12943-025-02375-x.
4
The Role of Protein Kinases in the Suppressive Phenotype of Myeloid-Derived Suppressor Cells.蛋白激酶在髓源性抑制细胞抑制表型中的作用
Int J Mol Sci. 2025 Jul 19;26(14):6936. doi: 10.3390/ijms26146936.
5
Immune cells in systemic lupus erythematosus: biology and traditional Chinese medicine therapy.系统性红斑狼疮中的免疫细胞:生物学与中医治疗
Acta Pharmacol Sin. 2025 Apr 17. doi: 10.1038/s41401-025-01554-2.
6
Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8 T and CAR-T cells.靶向 ROS 感应 Nrf2 增强肿瘤内 CD8 T 细胞和 CAR-T 细胞的抗肿瘤免疫。
Mol Ther. 2024 Nov 6;32(11):3879-3894. doi: 10.1016/j.ymthe.2024.08.019. Epub 2024 Aug 22.
7
Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism.重新探讨缺氧诱导因子和红细胞生成素相关因子 2 在调节巨噬细胞炎症和代谢中的作用。
Front Cell Infect Microbiol. 2024 Jul 25;14:1403915. doi: 10.3389/fcimb.2024.1403915. eCollection 2024.
8
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).髓源性抑制细胞:结直肠癌中关键的免疫抑制调节因子和治疗靶点(综述)。
Int J Oncol. 2024 Sep;65(3). doi: 10.3892/ijo.2024.5673. Epub 2024 Jul 26.
9
Emergency myelopoiesis in solid cancers.实体瘤中的应急性髓系造血
Br J Haematol. 2024 Sep;205(3):798-811. doi: 10.1111/bjh.19656. Epub 2024 Jul 23.
10
Targeting ROS in cancer: rationale and strategies.靶向癌症中的活性氧:原理与策略。
Nat Rev Drug Discov. 2024 Aug;23(8):583-606. doi: 10.1038/s41573-024-00979-4. Epub 2024 Jul 9.
髓源性抑制细胞、巨噬细胞和肿瘤细胞之间的相互作用影响实体瘤的炎症环境。
J Leukoc Biol. 2014 Dec;96(6):1109-18. doi: 10.1189/jlb.3A0414-210R. Epub 2014 Aug 28.
4
HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.高迁移率族蛋白B1通过促进髓源性抑制细胞的分化和抑制活性来增强免疫抑制作用。
Cancer Res. 2014 Oct 15;74(20):5723-33. doi: 10.1158/0008-5472.CAN-13-2347. Epub 2014 Aug 27.
5
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.内质网应激通过 TRAIL-R 介导的细胞凋亡调节髓源性抑制细胞的命运。
J Clin Invest. 2014 Jun;124(6):2626-39. doi: 10.1172/JCI74056. Epub 2014 May 1.
6
Effects of notch signaling on regulation of myeloid cell differentiation in cancer.Notch 信号通路对癌症中髓系细胞分化调控的影响。
Cancer Res. 2014 Jan 1;74(1):141-52. doi: 10.1158/0008-5472.CAN-13-1686. Epub 2013 Nov 12.
7
The emerging role of the Nrf2-Keap1 signaling pathway in cancer.Nrf2-Keap1 信号通路在癌症中的新兴作用。
Genes Dev. 2013 Oct 15;27(20):2179-91. doi: 10.1101/gad.225680.113.
8
Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.骨髓来源的抑制细胞功能被 Withaferin A 降低,它是印度人参根提取物中一种有效且丰富的成分。
Cancer Immunol Immunother. 2013 Nov;62(11):1663-73. doi: 10.1007/s00262-013-1470-2. Epub 2013 Aug 27.
9
Nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) modulates dendritic cell immune function through regulation of p38 MAPK-cAMP-responsive element binding protein/activating transcription factor 1 signaling.核因子红细胞 2(NF-E2)相关因子 2(Nrf2)通过调节 p38 MAPK-cAMP 反应元件结合蛋白/激活转录因子 1 信号通路调节树突状细胞免疫功能。
J Biol Chem. 2013 Aug 2;288(31):22281-8. doi: 10.1074/jbc.M113.483420. Epub 2013 Jun 17.
10
Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.Nrf2 在肺致癌发生过程中阻止起始但加速通过 Kras 信号通路的进展。
Cancer Res. 2013 Jul 1;73(13):4158-68. doi: 10.1158/0008-5472.CAN-12-4499. Epub 2013 Apr 22.